Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients

NCT01455974 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT01455974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01455974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2010
Completion date
September 30, 2011
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis, hypertension, left ventricular hypertrophy